MedPath

Biofrontera AG

Biofrontera AG logo
🇺🇸United States
Ownership
Public
Established
1997-01-01
Employees
95
Market Cap
$6M
Website
http://biofrontera.com

Biofrontera Inc. Negotiates Strategic Partnership Changes with German Parent Company

Biofrontera Inc. and Biofrontera AG are negotiating potential company combination or license agreement adjustments that could transfer rights and reduce transfer pricing for US products.

Biofrontera's Ameluz Secures Patent Extension to 2043, Targets $5.7B Acne Market

Biofrontera Inc. has secured FDA approval for a reformulated Ameluz nanoemulsion gel, extending patent protection until 2043 and allowing up to three tubes per treatment, potentially increasing revenue through larger average sales.

© Copyright 2025. All Rights Reserved by MedPath